To demonstrate the relationships
p-value was calculated by Mantel-Haenszel procedure (denote that 0.5 was used instead of 0 in the approximate calculations) The relationships of hypercholesterolemia to atherosclerotic events, such as CHD are now well established. [11] , [12] However, although CHD and stroke share many of the same risk factors, the relationship of cholesterol to stroke remains controversial. [8] . [13] This might be alternative reason for the risk difference between MRFS group and hTC group.
Our study presents several limitations: the short period of follow-up, the limited number of events, the truncation and the poten-tial bias such as selection bias and measurement bias. It should be noted that the number of atherosclerotic events in MRFS group was only 15 cases, and, as consequence, the reliability and the stability of risk difference are not fully taken in. In addition, since we defined the both groups by a single measurement of each component data per person (baseline), thus tending to produce misclassification (regression dilution bias). [14] We excluded 37 participants who had initiated medication during follow-up and this might be another limitation for our study. Difference between this excluded 37 medicated participants and 76 eligible hTC subjects in the frequencies of high blood pressure showed statistically significant (19.7% vs. 37.8%). However, differences in the mean TC level, BMI, glucose intolerance, TC, TG, smoking habits, alcohol habits were similar in both groups and did not reach statistically significance.
In summary, we found that atherosclerotic events occur more frequently in MRFS than in hTC group in worksite. In Japan, both cardio-and cerebro-vascular disease is major part of the public health concerns, because of its high prevalence and its unfavorable QOL due to a marked degree of consequent disability. Our findings suggest that a cluster of subclinical metabolic risk factors accelerate occurrences of atherosclerotic outcome, and we should focus intensely on a linkage of those risks, that is hyperglycemia, high blood pressure, obesity, and hypertriglyceridemia, as well as single hypercholesterolemia that is known widely as a potential atherosclerotic risk factor. Our MRFS group analysis showed that proportion of both glucose intolerance and obesity in atherosclerotic cases is higher than those in non-cases, and these results suggested that controls of both plasma glucose level and body weight (BMI) should be improved in MRFS in terms of preventing atherosclerotic outcome.
